TOTAL TRIALS
8
ACTIVE
2
SUSPENDED
1
RESTRICTED ADDENDA
3

VERIDIAN
LABS

Clinical trial registry. All active, completed, suspended, and terminated trials. Some records contain restricted addenda. Access to restricted content requires appropriate clearance level.

01

TRIAL REGISTRY

VL-2019-001
COMPLETED
Cortisol Modulation in Chronic Stress Disorder
VRL-4401 · PHASE II
INDICATION
Chronic Stress Disorder
ENROLLED
240
VIEW RECORD →
VL-2020-003
ACTIVE
Neuroinflammation Reduction in Early-Onset Alzheimer's
VRL-5502 · PHASE III
INDICATION
Early-Onset Alzheimer's Disease
ENROLLED
1840
VIEW RECORD →
VL-2018-007
COMPLETED
Selective Serotonin Reuptake Enhancement in Treatment-Resistant Depression
VRL-3301 · PHASE III
INDICATION
Treatment-Resistant Major Depressive Disorder
ENROLLED
980
VIEW RECORD →
VL-2021-011
ACTIVE
Immune Checkpoint Modulation in Metastatic Colorectal Cancer
VRL-6601 · PHASE II
INDICATION
Metastatic Colorectal Cancer
ENROLLED
320
VIEW RECORD →
VL-2022-015
COMPLETED
Circadian Rhythm Resynchronization via Melatonin Receptor Agonism
VRL-7701 · PHASE II
INDICATION
Circadian Rhythm Sleep-Wake Disorder
ENROLLED
180
VIEW RECORD →
VL-2023-019
SUSPENDED
Glial Cell Modulation in Chronic Pain
VRL-8801 · PHASE I
INDICATION
Chronic Neuropathic Pain
ENROLLED
48
⚠ RESTRICTED ADDENDUM EXISTS
VIEW RECORD →
VL-2020-009
TERMINATED
Telomere Stabilization in Accelerated Aging Syndrome
VRL-5901 · PHASE II
INDICATION
Hutchinson-Gilford Progeria Syndrome
ENROLLED
22
⚠ RESTRICTED ADDENDUM EXISTS
VIEW RECORD →
CLASSIFIED
VL-2024-023
CLASSIFIED
[TITLE REDACTED]
VRL-9901 · UNCLASSIFIED
INDICATION
[REDACTED]
ENROLLED
[REDACTED]
VIEW RECORD →
02

COMPOUND LIBRARY

Veridian Labs maintains a library of 47 proprietary compounds across 9 therapeutic areas. All compounds in active trials are synthesized under GMP conditions at the primary manufacturing facility.

Compound VRL-9901 is not listed in the public compound library. Requests for information about this compound should be directed to the Office of Research Compliance.

DISCLOSURE NOTICE

This registry is maintained in compliance with regulatory disclosure requirements. The presence of classified entries does not constitute confirmation of the nature or scope of the research described therein.

Compound structure
FIG. 1 — COMPOUND STRUCTURE, VRL-SERIES (REPRESENTATIVE)
VERIDIAN LABS · CLINICAL TRIAL REGISTRY · CONFIDENTIAL
REGISTRY CURRENT AS OF 2026-02-28